The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials

Documenti analoghi

• Apolipoprotein CIII correlates with lipoproteins in the fed state and is not regulated by leptin administration in states of hypoleptinemia induced by acute or chronic energy deficiency: Results from two randomised controlled trials
  di: Arantxa Ramirez‐Cisneros, et al.
  Pubblicazione: (2025)
• Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis
  di: Leonardo A. Mesquita, et al.
  Pubblicazione: (2024)
• Combined liraglutide and metformin therapy in overweight or obese women with polycystic ovary syndrome: A systematic review and meta‐analysis
  di: Jing Ling, et al.
  Pubblicazione: (2025)
• Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin–activin–follistatin– IGF ‐1 axis: Results from an exploratory, randomized, placebo‐controlled, crossover study
  di: Valeria Gutierrez de Piñeres, et al.
  Pubblicazione: (2025)
• Efficacy of GLP ‐1 receptor agonists in patients with obesity and heart failure with preserved ejection fraction: A systematic review and meta‐analysis of randomised controlled trials
  di: Armando Talavera, et al.
  Pubblicazione: (2025)